The Europe Serum Separation Gel Market would witness market growth of 6.3% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Serum Separation Gel Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $846 million by 2031. The UK market is exhibiting a CAGR of 5.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 7.2% during (2024 - 2031).
Continuous research and development efforts are focused on enhancing the performance of serum separation gel products. This includes improvements in gel formulations, tube designs, and manufacturing processes to achieve better separation efficiency, sample integrity, and compatibility with automated systems. Advancements in nanotechnology and biomaterials also influence the development of novel serum separation technologies.
Additionally, while serum separation gel has been the conventional method for separating serum from whole blood samples, there’s a growing trend toward gel-free separation methods. These methods rely on mechanical or physical barriers to separate serum from blood cells, eliminating the need for a gel barrier. Gel-free separation methods offer advantages such as faster processing times, reduced risk of gel-related interferences in assays, and compatibility with certain analytes or assays that may be affected by gel components.
The aging population in Europe is driving increased demand for senior healthcare services, including specialized care for older adults with chronic diseases and age-related health conditions. The aging of the European population is associated with an increased incidence of age-related and chronic illnesses, including diabetes, cancer, neurological disorders, and cardiovascular diseases. Thus, all these factors will uplift the regional market’s expansion in the coming years.
Based on Product Type, the market is segmented into Serum Separation Gel Integrated with Tube, and Serum Separation Gel Integrated without Tube. Based on End User, the market is segmented into Blood Bank, Hospital, Pharmaceutical & Companies, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The Germany market dominated the Europe Serum Separation Gel Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $846 million by 2031. The UK market is exhibiting a CAGR of 5.3% during (2024 - 2031). Additionally, The France market would experience a CAGR of 7.2% during (2024 - 2031).
Continuous research and development efforts are focused on enhancing the performance of serum separation gel products. This includes improvements in gel formulations, tube designs, and manufacturing processes to achieve better separation efficiency, sample integrity, and compatibility with automated systems. Advancements in nanotechnology and biomaterials also influence the development of novel serum separation technologies.
Additionally, while serum separation gel has been the conventional method for separating serum from whole blood samples, there’s a growing trend toward gel-free separation methods. These methods rely on mechanical or physical barriers to separate serum from blood cells, eliminating the need for a gel barrier. Gel-free separation methods offer advantages such as faster processing times, reduced risk of gel-related interferences in assays, and compatibility with certain analytes or assays that may be affected by gel components.
The aging population in Europe is driving increased demand for senior healthcare services, including specialized care for older adults with chronic diseases and age-related health conditions. The aging of the European population is associated with an increased incidence of age-related and chronic illnesses, including diabetes, cancer, neurological disorders, and cardiovascular diseases. Thus, all these factors will uplift the regional market’s expansion in the coming years.
Based on Product Type, the market is segmented into Serum Separation Gel Integrated with Tube, and Serum Separation Gel Integrated without Tube. Based on End User, the market is segmented into Blood Bank, Hospital, Pharmaceutical & Companies, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Becton, Dickinson, and Company
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Siemens Healthineers AG (Siemens AG)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Sysmex Corporation
- Charles River Laboratories International, Inc.
- QuidelOrtho Corporation
Market Report Segmentation
By Product Type- Serum Separation Gel Integrated with Tube
- Serum Separation Gel Integrated without Tube
- Blood Bank
- Hospital
- Pharmaceutical & Companies
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Serum Separation Gel Market by Product Type
Chapter 5. Europe Serum Separation Gel Market by End User
Chapter 6. Europe Serum Separation Gel Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Becton, Dickinson, and Company
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Agilent Technologies, Inc.
- Siemens Healthineers AG (Siemens AG)
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Sysmex Corporation
- Charles River Laboratories International, Inc.
- QuidelOrtho Corporation
Methodology
LOADING...
